PlainRecalls
FDA Drug Critical Class I Terminated

Zhonghua Niubian tablets, 2000mg, 6-count bottle, labeling is in foreign language

Reported: February 7, 2018 Initiated: March 7, 2017 #D-0563-2018

Product Description

Zhonghua Niubian tablets, 2000mg, 6-count bottle, labeling is in foreign language

Reason for Recall

Marked Without An Approved NDA/ANDA: FDA analysis found these products to contain sildenafil, an FDA approved drug for the treatment of erectile dysfunction, making these products unapproved drugs for which safety and efficacy have not been establish and therefore, subject to recall.

Details

Recalling Firm
A&H Focal Inc.
Units Affected
unknown
Distribution
NY and NJ through six retail stores named "Asian Food Markets"
Location
Staten Island, NY

Frequently Asked Questions

What product was recalled?
Zhonghua Niubian tablets, 2000mg, 6-count bottle, labeling is in foreign language. Recalled by A&H Focal Inc.. Units affected: unknown.
Why was this product recalled?
Marked Without An Approved NDA/ANDA: FDA analysis found these products to contain sildenafil, an FDA approved drug for the treatment of erectile dysfunction, making these products unapproved drugs for which safety and efficacy have not been establish and therefore, subject to recall.
Which agency issued this recall?
This recall was issued by the FDA Drug on February 7, 2018. Severity: Critical. Recall number: D-0563-2018.